Five-year results from the landmark trial show outcomes converging since year 1, with statistically comparable results on the primary endpoints and similar rates of valve failure.
After recurrent thromboembolic phenomena following his second surgical aortic valve replacement, a man in his 50s experiences transient episodes of neurologic symptoms suggestive of TIAs. What is the cause?
The new update to definitions of clinical endpoints for aortic valve disease trials gives more focus to secondary outcomes, composite safety and efficacy measures, and quality-of-life metrics.
Mortality differs from state to state and between nonwhite and white demographic groups, finds a new analysis of nationwide data since 2008.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A new analysis of PARTNER 2 data used echocardiographic data to assess structural valve deterioration between transcatheter and surgical approaches. We sort through the results and implications.
We mark 25 years as the nation’s top-ranked heart program by reflecting on key shifts in cardiovascular care over the past quarter century, with an eye toward what’s still ahead.
Check out our latest outcomes statistics in aortic valve replacement, aorta surgery, mitral valve repair and other realms of adult cardiac surgery. All in dynamic, scannable graphic form.
The next waves of progress in transcatheter aortic valve replacement are likely to involve expanding indications, valve refinements and new accessory treatments.
A large analysis of pooled PARTNER data eases concerns that endocarditis risk might be higher with transcatheter rather than surgical approaches to aortic valve replacement.
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.